190 related articles for article (PubMed ID: 37657507)
1. From cell factories to patients: Stability challenges in biopharmaceuticals manufacturing and administration with mitigation strategies.
Elsayed A; Jaber N; Al-Remawi M; Abu-Salah K
Int J Pharm; 2023 Oct; 645():123360. PubMed ID: 37657507
[TBL] [Abstract][Full Text] [Related]
2. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales.
Hummel J; Pagkaliwangan M; Gjoka X; Davidovits T; Stock R; Ransohoff T; Gantier R; Schofield M
Biotechnol J; 2019 Feb; 14(2):e1700665. PubMed ID: 29341493
[TBL] [Abstract][Full Text] [Related]
3. Ionic-liquid-based approaches to improve biopharmaceuticals downstream processing and formulation.
Almeida C; Pedro AQ; Tavares APM; Neves MC; Freire MG
Front Bioeng Biotechnol; 2023; 11():1037436. PubMed ID: 36824351
[TBL] [Abstract][Full Text] [Related]
4. Protein aggregation and immunogenicity of biotherapeutics.
Pham NB; Meng WS
Int J Pharm; 2020 Jul; 585():119523. PubMed ID: 32531452
[TBL] [Abstract][Full Text] [Related]
5. Potential and Applications of Nanocarriers for Efficient Delivery of Biopharmaceuticals.
Zeb A; Rana I; Choi HI; Lee CH; Baek SW; Lim CW; Khan N; Arif ST; Sahar NU; Alvi AM; Shah FA; Din FU; Bae ON; Park JS; Kim JK
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33291312
[TBL] [Abstract][Full Text] [Related]
6. Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions.
Szkodny AC; Lee KH
Annu Rev Chem Biomol Eng; 2022 Jun; 13():141-165. PubMed ID: 35300518
[TBL] [Abstract][Full Text] [Related]
7. Application of Formulation Principles to Stability Issues Encountered During Processing, Manufacturing, and Storage of Drug Substance and Drug Product Protein Therapeutics.
Vitharana S; Stillahn JM; Katayama DS; Henry CS; Manning MC
J Pharm Sci; 2023 Nov; 112(11):2724-2751. PubMed ID: 37572779
[TBL] [Abstract][Full Text] [Related]
8. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
[TBL] [Abstract][Full Text] [Related]
9. Methods for addressing host cell protein impurities in biopharmaceutical product development.
Tuameh A; Harding SE; Darton NJ
Biotechnol J; 2023 Mar; 18(3):e2200115. PubMed ID: 36427352
[TBL] [Abstract][Full Text] [Related]
10. Applications of Raman Spectroscopy in Biopharmaceutical Manufacturing: A Short Review.
Buckley K; Ryder AG
Appl Spectrosc; 2017 Jun; 71(6):1085-1116. PubMed ID: 28534676
[TBL] [Abstract][Full Text] [Related]
11. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Srai JS; Badman C; Krumme M; Futran M; Johnston C
J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
[TBL] [Abstract][Full Text] [Related]
12. Maintaining consistent quality and clinical performance of biopharmaceuticals.
Lamanna WC; Holzmann J; Cohen HP; Guo X; Schweigler M; Stangler T; Seidl A; Schiestl M
Expert Opin Biol Ther; 2018 Apr; 18(4):369-379. PubMed ID: 29285958
[TBL] [Abstract][Full Text] [Related]
13. Progress in biopharmaceutical development.
Kesik-Brodacka M
Biotechnol Appl Biochem; 2018 May; 65(3):306-322. PubMed ID: 28972297
[TBL] [Abstract][Full Text] [Related]
14. Exploring the potential of machine learning for more efficient development and production of biopharmaceuticals.
Puranik A; Dandekar P; Jain R
Biotechnol Prog; 2022 Nov; 38(6):e3291. PubMed ID: 35918873
[TBL] [Abstract][Full Text] [Related]
15. Continuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?
Rathore AS; Thakur G; Kateja N
Biotechnol Bioeng; 2023 Feb; 120(2):333-351. PubMed ID: 36111450
[TBL] [Abstract][Full Text] [Related]
16. From cell line development to the formulated drug product: The art of manufacturing therapeutic monoclonal antibodies.
Carrara SC; Ulitzka M; Grzeschik J; Kornmann H; Hock B; Kolmar H
Int J Pharm; 2021 Feb; 594():120164. PubMed ID: 33309833
[TBL] [Abstract][Full Text] [Related]
17. Antibody disulfide bond reduction and recovery during biopharmaceutical process development-A review.
Ren T; Tan Z; Ehamparanathan V; Lewandowski A; Ghose S; Li ZJ
Biotechnol Bioeng; 2021 Aug; 118(8):2829-2844. PubMed ID: 33844277
[TBL] [Abstract][Full Text] [Related]
18. Innovative Drying Technologies for Biopharmaceuticals.
Sharma A; Khamar D; Cullen S; Hayden A; Hughes H
Int J Pharm; 2021 Nov; 609():121115. PubMed ID: 34547393
[TBL] [Abstract][Full Text] [Related]
19. Upstream continuous processing: recent advances in production of biopharmaceuticals and challenges in manufacturing.
Matanguihan C; Wu P
Curr Opin Biotechnol; 2022 Dec; 78():102828. PubMed ID: 36332340
[TBL] [Abstract][Full Text] [Related]
20. The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing.
Esmonde-White KA; Cuellar M; Lewis IR
Anal Bioanal Chem; 2022 Jan; 414(2):969-991. PubMed ID: 34668998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
